Abstract Estrogens rapidly regulate neuronal activity within seconds-to-minutes, yet it is unclear how estrogens interact with neural circuits to rapidly coordinate behavior. This study examines whether 17-beta-estradiol interacts with an opioidergic network to achieve rapid modulation of a vocal control circuit. Adult plainWn midshipman Wsh emit vocalizations that mainly diVer in duration, and rhythmic activity of a hindbrain-spinal vocal pattern generator (VPG) directly establishes the temporal features of midshipman vocalizations. VPG activity is therefore predictive of natural calls, and 'Wctive calls' can be elicited by electrical microstimulation of the VPG. Prior studies show that intramuscular estradiol injection rapidly (within 5 min) increases Wctive call duration in midshipman. Here, we delivered opioid antagonists near the VPG prior to estradiol injection. Rapid estradiol actions on Wctive calling were completely suppressed by the broad-spectrum opioid antagonist naloxone and the mu-opioid antagonist beta-funaltrexamine, but were unaVected by the kappa-opioid antagonist nor-binaltorphimine. Unexpectedly, prior to estradiol administration, all three opioid antagonists caused immediate, transient reductions in Wctive call duration. Together, our results indicate that: (1) vocal activity is modulated by opioidergic networks, conWrming hypotheses from birds and mammals, and (2) the rapid actions of estradiol on vocal patterning depend on interactions with a mu-opioid modulatory network.
Introduction
Estrogens rapidly regulate behavior within minutes in a variety of contexts, most notably the sexual behavior of male rats (Cross and Roselli 1999) and Japanese quail (Cornil et al. 2006b ). Estrogens also act within seconds-tominutes on the neurophysiological properties of striatal, hippocampal and hypothalamic neurons (Qiu et al. 2003; Woolley 2007) . These actions on neuronal excitability occur via interactions with ion channels and/or neurotransmitter receptors, including those for opioids (reviews: Kelly and Ronnekleiv 2002; Cornil et al. 2006a) . Taken together, these observations suggest that the mechanisms established for estrogen action on neuronal activity mediate the rapid behavioral eVects of estrogens. However, it remains largely unknown how estrogens rapidly modulate discrete networks of neurons that pattern behavioral output. In principle, estrogen-dependent modulation could be via either direct eVects on central pattern generators or indirect eVects on aVerent modulatory networks.
17--Estradiol (E 2 ) modulates the activity of a vocal central pattern generator in a sound-producing teleost Wsh, the plainWn midshipman (Porichthys notatus) (RemageHealey and Bass 2004, 2007) . Male midshipman establish and defend nests they build under rocky shelters, and emit long-duration (>1 min) advertisement calls known as "hums" to attract females to their nests. Adults of both sexes emit short-duration (»100 ms) "grunts" during aggressive encounters (Brantley and Bass 1994; Bass and McKibben 2003) . The rhythmic activity of hindbrain-spinal vocal pattern generator (VPG; see Fig. 1 ) directly establishes the fundamental frequency and duration of midshipman calls (Bass and Baker 1990) . The output of the VPG ('Wctive calls') can be evoked by excitation of midbrain and hindbrain sites (Bass and Baker 1990; Weeg et al. 2005; Kittelberger et al. 2006) , and the temporal Wring properties of the VPG directly establish the temporal features of natural calls (Bass and Baker 1990) . Intramuscular E 2 injection rapidly (within 5 min) increases the duration of Wctive calls in adult male and female midshipman Bass 2004, 2007) , and these eVects are both short-lived (lasting 30-45 min) and stereospeciWc. Androgens and glucocorticoids also cause rapid changes in Wctive calling in this species and candidate receptor mechanisms have been identiWed by blocking these acute eVects with cyproterone acetate (antiandrogen) and RU486 (antiglucocorticoid), respectively (Remage-Healey and Bass 2004) . A similar candidate receptor mechanism has not yet been identiWed for the rapid eVects of E 2 . The rapid actions of E 2 are localized to the hindbrain-spinal region that contains the VPG (Remage-Healey and Bass 2004), but whether E 2 acts directly on the VPG itself, or via indirect actions on neurons that modulate the VPG, is unknown. The midshipman model system therefore presents an opportunity to identify mechanism(s) of acute estrogen action on a deWned neural circuit (shared by all major vertebrate lineages, see ) that patterns vocalizations.
Here, we test the hypothesis that an opioidergic network provides a modulatory mechanism for the rapid actions of E 2 in midshipman. Our focus on opioidergic mechanisms is related to three previous observations. First, rapid E 2 actions on mammalian hypothalamic neurons occur via interactions with opioidergic systems (Kelly et al. 1992; Qiu et al. 2003) . Second, a membrane-bound receptor that is proposed to mediate rapid corticosteroid suppression of clasping behavior in amphibians exhibits opioid-like binding properties (Evans et al. 2000) . Lastly, longer-term (i.e., hours to days) interactions between steroids (estrogens and progestins) and opioidergic neurons have emerged in studies examining the regulation of sexual receptivity in rodents (Eckersell et al. 1998; Sinchak and Micevych 2001; Acosta-Martinez and Etgen 2002) . We report results for three opioid antagonists: naloxone, a broad-spectrum opioid blocker; beta-funaltrexamine, a blocker speciWc to mu-opioid neurons in other vertebrates; and nor-binaltorphimine, a blocker speciWc to kappa-opioid neurons in other vertebrates (Bodnar and Klein 2006) . We note that the receptor speciWcity of these antagonists has not been fully characterized for opioid receptors in teleosts, but that opioid receptor subtypes are broadly conserved among vertebrates (Brooks et al. 1994; Ebbesson et al. 1996; Khalap et al. 2005 , see discussion).
Materials and methods

Animals
Midshipman Wsh have two adult male morphs that diverge in a large suite of traits including reproductive tactics and vocal behaviors (Brantley and Bass 1994) . Type I males build and guard nests in the intertidal zone, whereas smaller type II males sneak and satellite spawn in attempt to steal fertilizations from type I's. Only type I males are known to produce the long-duration advertisement hums as well as extended trains of brief agonistic grunts and growls that are intermediate in duration between hums and grunts (Bass and McKibben 2003) . Type II males and females are only known to generate grunts in non-spawning contexts. This study included 40 type I males (13-20 cm standard length) collected from nest sites in northern California and Washington state. While females have the highest plasma E 2 levels, detectable levels of circulating E 2 are found in close to 70% of type I males during pre-nesting and nesting periods (Sisneros et al. 2004 ). Also, aromatase-containing glial cells surround the dorsolateral aspect of the vocal motor nucleus (VMN) and have processes that ramify throughout the VMN which likely provide a local source of E 2 via aromatization of circulating testosterone (Forlano et al. 2001; Sisneros et al. 2004 ).
Evoked activity of the vocal pattern generator (VPG) Electrophysiology procedures closely followed those outlined in earlier studies with midshipman Wsh (Bass and Baker 1990; Goodson and Bass 2000; Remage-Healey and Bass 2004 ). The brain and rostral spinal cord were exposed by dorsal craniotomy under general anesthesia (0.025% benzocaine; Sigma) and long-lasting analgesia (0.25% bupivacaine; Abbott Laboratories, Chicago, IL; with 0.01 mg/mg epinephrine; International Medication Systems, El Monte, CA). Following surgery, Wsh were stabilized in a plexiglass tank during recovery and perfused through the mouth with fresh saltwater maintained at 17°C with a Peltier device. Exposed brain areas were covered with Flouroinert (3 M Corp., St. Paul, MN), and intramuscular injections of pancuronium bromide (0.5 mg/kg; Astra Pharmaceutical Products, Westborough MA) were used for immobilization. Brief electrical stimuli (pulse width = 0.1 ms, frequency = 250 Hz, duration = 25 ms) were delivered via an insulated tungsten electrode exposed at the tip (Fig. 1b) to a hindbrain-spinal vocal site VPP , formerly designated as VM , that is vocally active (Remage-Healey and Bass 2004; . Electrically evoked vocal motor volleys were recorded with an extracellular electrode (TeXon-coated silver wire with exposed ball tip) placed on a ventral occipital nerve root that carries vocal motor axons to the ipsilateral vocal muscle attached to the lateral walls of the swim bladder (Fig. 1b) . Activity recorded from either left-or right-side occipital nerve root reXects bilateral output (Bass and Baker 1990) . Rhythmic vocal motor volleys occurred as discrete bursts (Wctive calls, Fig. 1a -c) similar to natural grunts (see Brantley and Bass 1994) and were recorded at 1-s intervals. Recordings were digitized on a Macintosh using IGOR Pro software (Wavemetrics, Inc., Lake Oswego, OR). The duration of each Wctive call was measured from the recordings and the mean burst duration was computed for each time point and normalized to 100% of baseline output.
Delivery of opioid antagonists
All opioid antagonists were obtained from Tocris Bioscience (Ellisville, MO) and dissolved in buVered teleost Goodson and Bass 2002) . The hindbrain-spinal vocal pattern generator (VPG) consists of a vocal motor nucleus (VMN) that innervates the vocal swimbladder muscles via occipital nerve roots, an adjacent column of vocal pacemaker neurons (VPN) which temporally pattern the activity of the VMN, and a rostral vocal prepacemaker nucleus (VPP). The VPG receives descending input from vocal-acoustic centers (VAC) in the hindbrain (h), midbrain (m), and forebrain (f). Electrical microstimulation of the VPP region (solid electrode) elicits patterned Wctive calls (traces below; illustrations only and not real data) recorded via extracellular electrode adjacent to the occipital nerve root. Also depicted is the drug delivery electrode (dashed electrode) within the fourth ventricle. MO medulla oblongata, CBL cerebellum, MD midbrain, TEL telencephalon. c-e Illustrations of three modulatory eVects on midshipman hindbrain-spinal VPG activity. Traces are 250 ms in duration (scale bar 100 ms) and are depicted for illustration purposes only. c Functional mu-and/or kappa-opioid circuits within the VPG region are required for baseline Wctive call duration. d, e Rapid actions of E 2 on Wctive call duration require the presence of functional mu-opioidergic circuits. In the absence of functional mu-opioid circuits (d) Wctive call duration remains at baseline. The combined rapid actions of E 2 and mu-opioidergic circuits (e) result in increased Wctive call duration Ringer's (Forster-Taggart) solution (all solutions had pH between 6.81 and 8.19). Fictive calls evoked from the hindbrain-spinal VPP region were considered stable when a single Wctive call was entrained to each stimulus. Once stability was established, a series of ten Wctive calls was evoked at 1-s intervals to determine baseline (pre-drug) vocal motor output. Immediately following the baseline period, either saline vehicle (n = 4 animals) or one of three opioid receptor antagonists was pressure injected (see below) into the hindbrain (fourth) ventricle that directly borders the VMN (see Fig. 1b ) (Bass and Baker 1990; Bass et al. 1994) . Antagonists included the broad-spectrum opioid receptor antagonist naloxone (1, 10, 25 mM; n = 6, 4, 4 animals each, respectively), the mu-speciWc opioid antagonist beta-funaltrexamine (1, 10 mM; n = 4 each), and the kappa-speciWc opioid antagonist nor-binaltorphimine (0.66, 6.6 mM; n = 3 each). Drug doses were based on previous studies of opioid-steroid interactions (Evans et al. 2000; Acosta-Martinez and Etgen 2002; Ceccarelli et al. 2004; Schmitt and Kaufman 2005) . The standard dose sequence (1, 10 mM) was lowered slightly for nor-binaltorphimine due to limited reagent availability; it is an eVective kappaopioid antagonist in both mammalian and non-mammalian vertebrates (Bradford et al. 2005) .
Drugs and vehicle were delivered via a glass micropipette (microWlament 6010 1.0 mm OD, AM Systems, Carlsborg, WA) with broken tips (18-20 m) using a picospritzer (Biomedical Engineering, Thornwood, NY). Only one dose of opioid antagonist or vehicle was used per experiment (i.e., in each animal). Injection parameters followed those well-established for this preparation (one pressure pulse per second at 30 psi and pulse duration of 10 ms for estimated infusion volume of approximately 0.16 nl; see Goodson and Bass 2000; Kittelberger et al. 2006 ). The picospritzer electrode was checked before and immediately following each experiment to verify that pressure delivery was functional. A simultaneous recording of ten Wctive calls was obtained (as above) concurrent with pressure delivery of solutions to identify any instantaneous eVects of either drug or saline delivery on vocal motor patterning (see also the experiment timeline in Fig. 1a) . Two subsequent recordings of 15 Wctive calls were obtained at 5 and 15 min following solution delivery (all treatments prior to E 2 administration; see Fig. 1a ) to determine whether drugs or saline altered vocal motor patterning. Five minutes after the 15-min post-drug recording, Wsh were administered an intramuscular injection (dorsal trunk muscle) of E 2 (0.02 mg/kg) via a pre-inserted 23-G butterXy needle. This treatment dose rapidly increases Wctive call duration (within 5 min and lasting up to 30 min) in type I male midshipman (Remage-Healey and Bass , 2007 . Immediately following the injection, a subsequent series of 15 Wctive calls were obtained at 5, 15, 30, 45, and 60 min, and each time point was standardized to 100% of the baseline output. After the last recording, blood samples were obtained from the gill arch (Remage-Healey and Remage-Healey and Bass 2006) , and plasma was analyzed for E 2 using enzyme immunoassay (Cayman Chemical, Ann Arbor, MI, techniques reported previously in Remage-Healey and Bass 2004 , 2007 . Plasma E 2 levels were conWrmed to be elevated (mean = 34.52 ng/ml § 8.01 SEM; n = 16) for a subset of animals that received E 2 injections (see also Remage-Healey and Bass 2004).
Analysis
As described above, Wctive call durations were sampled and standardized to 100% of baseline. Statistical analyses of the eVects of drugs on Wctive call duration were performed using Statview 4.57. Repeated-measures ANOVA was performed for data from all treatments for analysis of treatment eVects over time in a within-and between-subjects design. Tukey's post hoc tests are reported for betweensubject eVects for comparisons of saline versus drug treatments for P < 0.05.
Results
Overview
We Wrst show that each of the opioid antagonists used herenaloxone, beta-funaltrexamine, and nor-binaltorphiminecaused a rapid and brief (either immediate or within 5 min of infusion) suppression of Wctive calling when delivered to the hindbrain VPP region. All antagonists had similarly brief eVects when initially applied, but calling recovered to baseline quickly (within 5-10 min). In contrast, subsequent attenuation of rapid E 2 eVects on Wctive calling was both antagonist-speciWc and prolonged, lasting up to 30-60 min. This encompasses the duration of E 2 's actions on Wctive calling in this species Bass 2004, 2007) . Only naloxone and the mu-opioid-speciWc antagonist betafunaltrexamine, but not the kappa-opioid antagonist nor-binaltorphimine, inhibited E 2 's eVects on calling.
Antagonists alone
Naloxone
The broad-spectrum opioid antagonist naloxone (1, 10, and 25 mM) caused a transient reduction in Wctive call duration, in a dose-dependent manner (Fig. 2a ). There were signiWcant eVects of time-after-delivery (F = 8.74; df = 3,42; P = 0.0001), a dose £ time interaction (F = 3.36; df = 9.42; P = 0.003), and a non-signiWcant trend for the eVect of dose (F = 3.12; df = 3,14; P = 0.06). Tukey's post hoc test revealed that naloxone produced signiWcant (P < 0.05) reductions in Wctive call duration at 5 min after delivery for all three doses (1, 10, 25 mM) when compared to saline alone. Fictive call duration was indistinguishable from baseline at 15 min following naloxone treatment. For the 5-min time point, the response to naloxone was linearly dose-dependent; i.e., there was a larger reduction in Wctive call duration as the doses of naloxone increased.
Beta-funaltrexamine
The mu-speciWc opioid antagonist beta-funaltrexamine (1, 10 mM) also caused a transient reduction in Wctive call duration (Fig. 2b ). There were signiWcant eVects of timeafter-delivery (F = 3.69; df = 3.27; P = 0.04), a dose £ time interaction (F = 5.55; df = 6.27; P = 0.0007), and no signiWcant eVect of dose (F = 1.21; df = 2.9; P = 0.34). Tukey's post hoc test revealed that beta-funaltrexamine produced signiWcant (P < 0.05) reductions in Wctive call duration immediately upon delivery ('spritz'; 10 mM dose) and at 5 min after delivery (1 mM dose) when compared to saline alone. While the time-dependence of the response to beta-funaltrexamine diVered slightly for the two doses, they were similar in temporal pattern. That is, the larger dose (10 mM) produced only an immediate reduction in Wctive calling and the lower dose (1 mM) produced a reduction only at 5 min after delivery of the drug; each recovered to baseline by the next time point tested, i.e., within at least 5 min (10 mM) or 10 min (1 mM). Fictive call duration was indistinguishable from baseline at 15 min following beta-funaltrexamine treatment.
Nor-binaltorphimine
The kappa-speciWc opioid antagonist nor-binaltorphimine (0.66, 6.6 mM) also caused a transient reduction in Wctive call duration that was, like naloxone, dose-dependent (Fig. 2c ). There were signiWcant eVects of time-after-delivery (F = 11.43; df = 3.21; P = 0.0001), a dose £ time interaction (F = 11.91; df = 6.21; P < 0.0001), and a signiWcant eVect of dose (F = 29.7; df = 2.7; P = 0.0004). Tukey's post hoc test revealed that nor-binaltorphimine produced signiWcant (P < 0.05) reductions in Wctive call duration immediately upon delivery (0 min; 6.6 mM dose) and at 5 min after delivery (0.66 and 6.6 mM doses) when compared to saline alone. Fictive call duration was indistinguishable from baseline at 15 min following nor-binaltorphimine treatment. Similar to beta-funaltrexamine, the dose-dependence of the response to nor-binaltorphimine was apparent in that only the highest dose (6.6 mM) produced an immediate reduction in Wctive calling. Unlike beta-funaltrexamine, both low and high doses produced reductions in Wctive calling at the 5-min time point. Similar to both naloxone and beta-funaltrexamine, Wctive call suppression that was present at 5 min recovered to baseline at the next time point tested, i.e., 15 min after picospritzing the drug.
Antagonists together with E 2
Naloxone
The broad-spectrum opioid antagonist naloxone (1, 10, and 25 mM) caused suppression of E 2 's rapid eVects on Wctive call duration that was dose-dependent (Fig. 3a) . There were signiWcant eVects of time-after-injection (F = 2.43; df = 5.60; P = 0.04), a dose £ time interaction (F = 2.23; df = 15.60; P = 0.01), and a signiWcant eVect of naloxone dose (F = 5.33; df = 3.12; P = 0.01) when comparing naloxone + E 2 treatments versus saline + E 2 treatment. Tukey's post hoc test revealed that naloxone + E 2 treatments produced signiWcantly shorter Wctive call duration from saline + E 2 treatment at 5 min (10 and 25 mM), 
Beta-funaltrexamine
The mu-speciWc opioid antagonist beta-funaltrexamine (1, 10 mM) also suppressed E 2 's rapid eVects on Wctive call duration (Fig. 3b) . There was no signiWcant eVect of timeafter-injection (F = 0.68; df = 5.45; P = 0.64), but there was a signiWcant dose £ time interaction (F = 3.44; df = 10.45; P = 0.002) and a signiWcant eVect of beta-funaltrexamine dose (F = 4.26; df = 2.9; P = 0.05) when comparing betafunaltrexamine + E 2 treatments versus saline + E 2 treatment. Like naloxone, Tukey's post hoc test revealed that beta-funaltrexamine + E 2 treatments produced signiWcantly shorter Wctive call duration from saline + E 2 treatment at 5 min (1 and 10 mM), 15 min (1 mM), and 30 min (1 mM). Thus, unlike naloxone, only the low (1 mM) dose of betafunaltrexamine was eVective in suppressing the entire timecourse of rapid E 2 actions, while the response to the high (10 mM) dose was no longer signiWcantly diVerent from the saline + E 2 treatment after 15 min.
Nor-binaltorphimine
Unlike naloxone and beta-funaltrexamine, the kappa-speciWc antagonist nor-binaltorphimine (0.66, 6.6 mM) had no signiWcant eVect on the rapid increase in Wctive call duration induced by E 2 (Fig. 3c ). There was a signiWcant eVect of time-after-injection (response to E 2 ; F = 10.70; df = 5.35; P < 0.0001), but there was no time £ dose interaction (F = 0.57; df = 10.35; P = 0.83), and no signiWcant eVect of binaltorphimine dose (F = 0.42; df = 2.7; P = 0.67) when comparing nor-binaltorphimine + E 2 treatments versus saline + E 2 treatment. Tukey's post hoc test did not detect signiWcant diVerences between nor-binaltorphimine + E 2 and saline + E 2 treatment for any time point at any dose. It is possible that a higher dose of nor-binaltorphimine would have caused suppression of Wctive calling. However, the current dose regimen matched the order of magnitude for the other opioid antagonists used in this study (micro-to milli-molar range) and is within the high-range of doses for eVective kappa-opioid blockade as reported in the literature (Gogas et al. 1996; Mitchell et al. 2005; Bodnar and Klein 2006; Pascoe et al. 2008) .
Discussion
This study reports that intracerebroventricular microinjection of opioid antagonists can acutely inhibit Wctive calling in midshipman Wsh. We also report that the rapid neuromodulation of Wctive calling by E 2 is suppressed during speciWc inhibition of a central mu-opioidergic network. Our Wndings are therefore consistent with the hypothesis that rapid E 2 actions on hindbrain-spinal VPG activity occur via interactions with a central mu-opioidergic network whose activation, in turn, modulates the VPG (as summarized in Fig. 1 ).
Opioidergic network and vocal mechanisms
This study provides evidence that opioids are neuromodulatory in contexts outside of their well-established role in regulating nociception and reinforcement/reward via actions in the forebrain (Bodnar and Klein 2006) . The current observation that opioidergic neurons are involved in modulating vocal motor mechanisms may not be unique to midshipman and 30 min. In contrast, the kappa-opioid-speciWc antagonist nor-binaltorphimine (c) produces no eVect on the rapid actions of E2, indicating that the observed actions are mu-opioid-speciWc. *P < 0.05 for Tukey's post hoc test for between-subject comparisons of Wctive calling during infusion of antagonists versus vehicle (saline) Wsh, since opioids and their receptors are expressed throughout the song-control pathway in oscine (Deviche et al. 1993 ) and non-oscine (Durand et al. 1998) songbirds. Furthermore, opioids regulate vocal behaviors in both songbirds and mammals (Riters et al. 2005; Bodnar and Klein 2006) , and, consistent with these earlier observations, the current study provides neurophysiological evidence that opioidergic neurons participate in the patterning of vocalizations.
Both the mu-speciWc (beta-funaltrexamine) and the kappa-speciWc (nor-binaltorphimine) opioid antagonists caused immediate suppression of Wctive call duration during infusion ('spritz'; latency < 1 min), whereas the broadspectrum opioid antagonist naloxone caused vocalization suppression after a latency of 5 min. Therefore, suppression was common to all three antagonists as was a rapid recovery to baseline. Relative to the other antagonists, the naloxone eVect was delayed but similarly short-lived, which may relate to diVerences in the ability of each drug to penetrate neural tissue due to chemical structure or potency (see also Martin et al. 2006; Chaijale et al. 2008) . It is noteworthy that the binding aYnity of opioid antagonists to mu-and kappa-opioid receptors have been well-characterized for mammals, but not yet for teleost Wshes. A lack of strict dose-dependence for these opioid antagonist treatments on Wctive calling makes non-speciWc eVects of microinjection (such as concentration-dependent changes in pH or other interfering substances) unlikely. However, we cannot formally rule out the possibility of immediate and non-speciWc artifacts of microinjection on vocal motor network properties given that all of the antagonists, in general, suppress Wctive call duration.
Opioid peptide and receptor expression in the midshipman central nervous system is currently un-described. Opioids and their receptors are highly conserved among vertebrates (Khalap et al. 2005) , and neuroanatomical evidence for opioid networks exist for other teleost Wshes (Brooks et al. 1994; Ebbesson et al. 1996) . In coho salmon, mu-opioid binding sites are reported throughout the telencephalon, diencephalon and mesencephalon (Ebbesson et al. 1996) , but the distribution of mu-opioid binding sites in the hindbrain are currently unknown in any teleost (delta-opioid receptors are found in the hindbrain of zebraWsh, speciWcally in the periventricular zone and abutting the nucleus of the medial longitudinal fasciculus, Porteros et al. 1999) . The indication that a mu-opioidergic network is critical for rapid actions of estrogens in midshipman Wsh is intriguing in light of the observation that brain mu-opioid systems are the most highly conserved among vertebrates (Li et al. 1996; Darlison et al. 1997) .
Opioidergic neurons that modulate midshipman vocal patterning could have multiple neuroanatomical origins. One of the major descending opioid projections in vertebrates is the midbrain periaqueductal gray (PAG, Behbehani 1995), a critical node linking forebrain to hindbrain vocal neurons in midshipman Wsh (see Kittelberger et al. 2006 , PAG is part of the mVAC in Fig 1 top) as well as in mammals (Jurgens 2008) . The current Wndings are consistent with the hypothesis that descending opioidergic neurons from the PAG have terminals in the hindbrain-spinal VPG, and that their activity contributes to the rapid modulation of vocalizations in midshipman. This hypothesis predicts that a subset of the projections from the PAG to the VPG consist of opioidergic processes that are rapid modulated by estrogens (directly or indirectly, see below).
Opioids and rapid estrogen mechanisms
We report that mu-opioidergic antagonists block the rapid actions of E 2 during a 15-60 min period after microinjection into the hindbrain ventricle adjacent to the VPG. This indicates that opioid blockers exert long-lasting eVects on the VPG comprised of mechanisms that could be substantially diVerent from the immediate (0-5 min) inhibitory eVects of opioid blockers on Wctive calls. Opioid agonists and antagonists are known to have delayed (minutesto-hours) modulatory actions on network function (Brown et al. 1998) , which consist of mechanisms distinct from rapid opioidergic (seconds-to-minutes) actions on neural activity (Heinricher 2003; Nugent et al. 2007 ). The current results suggest that similarly divergent acute versus delayed opioid mechanisms can each exert modulatory inXuences on the VPG circuit in midshipman.
One mechanism to account for the current Wndings is that opioid antagonists broadly suppress neuronal activity, including activity within the VPG, and that this suppression precludes the rapid actions of E 2 on the VPG. Consistent with this hypothesis, opioid agonists and antagonists exert long-lasting suppression of activity within neural circuits in a variety of contexts (Bennett and Mayer 1979; Cheng et al. 1986; Charpak et al. 1988) . However, in the current experiments, the midshipman VPG recovered from suppression (i.e., returned to 100% of baseline Wctive calling) within 5-10 min following treatment with all three opioid receptor antagonists. Secondly, mu-opioid blockade suppressed baseline VPG activity (Fig. 2b) and subsequent rapid E 2 actions (Fig. 3b ), yet kappa-opioid blockade only rapidly suppressed VPG activity (Fig. 2c) , but did not subsequently inXuence E 2 's rapid actions (Fig. 3c) . These Wndings together indicate that there are speciWc modulatory interactions between E 2 and a candidate mu-opioidergic network in the midshipman VPG region.
The candidate cellular mechanism(s) for combined E 2 /mu-opioid regulation of the VPG include either E 2 binding directly to opioid receptors (Gutierrez et al. 1998 ), or to nonclassical binding sites on opioidergic neurons (Lagrange et al. 1997) . These nonclassical actions of E 2 could occur either directly on modulatory mu-opioidergic neurons, or indirectly via an as yet unidentiWed modulatory input aVerent to mu-opioidergic neurons. The acute nature of our Wndings indicate that the site of rapid E 2 action within the VPG region is a nonclassical estrogen-binding site. Although the selective estrogen-receptor modulator ICI 182,780 potently blocks long-term estrogen-receptor mechanisms in other teleosts (e.g., Menuet et al. 2005; Pinto et al. 2006a Pinto et al. , 2006b ), pilot studies indicate that ICI is ineVective at modulating E 2 's rapid actions on vocal patterning in midshipman Wsh (Remage-Healey and Bass, unpublished observations). The binding site which mediates rapid E 2 eVects in midshipman may therefore be structurally dissimilar to the nuclear estrogen receptor (i.e., a membrane receptor/ion channel); alternatively, the rapid actions of E 2 could be mediated by nonclassical mechanisms associated with the canonical cytosolic estrogen receptor(s) (e.g., Vasudevan et al. 2005) . Previous evidence from rats indicates that E 2 increases the availability of mu-opioid receptors in hypothalamic inhibitory neurons (Torres-Reveron et al. 2009 ), suggesting that the rapid eVects of E 2 observed here could be via similarly nonclassical interactions with hindbrain/spinal GABAergic neurons that are mu-opioid responsive. Although more neuroanatomical evidence is needed for teleosts, E 2 can modulate opioidergic function in the brainstem of rats (Tashiro et al. 2008) and opioid receptor mRNA is co-localized with estrogen-receptor positive cells in brainstem circuits (Flores et al. 2003) .
The rapid E 2 /opioidergic modulation reported here is a part of a growing number of reports indicating that steroids interact with opioidergic systems to achieve rapid actions on neuronal activity. Steroids and steroidal drugs interact directly with opioid receptors, including mu-opioid receptors, to alter binding aYnities for endogenous opioids and subsequent neuronal activity (Maggi et al. 1996; SanMartin et al. 1999; Sajadi et al. 2007; Brown et al. 2008) . A membrane glucocorticoid receptor recently isolated in newts exhibits kappa-opioid binding properties, and has been proposed to mediate the rapid actions of corticosterone on reproductive clasping behavior (Evans et al. 2000) . In guinea pig hypothalamus, E 2 rapidly inhibits the mu-opioid eVector system (Kelly et al. 1992) , although not via a direct interaction with opioid receptors per se (Qiu et al. 2003) . In contrast, in rat hypothalamus, E 2 causes mu-opioid receptor traYcking inward from the membrane (internalization) within 30 min, and this eVect can be blocked by treatment with the broad-spectrum opioid blocker naltrexone (Eckersell et al. 1998; Sinchak and Micevych 2001) . Micevych and colleagues have proposed that E 2 causes rapid release of opioid peptides, which then bind to mu-opioid receptors, leading to their internalization. The results of the current study are consistent with this model from rat hypothalamus, and support the hypothesis that the rapid eVects of E 2 cause the release of mu-opioids within the VPG and thereby increase Wctive call duration. This model for the midshipman VPG generates two speciWc predictions: (1) opioidergic modulatory neurons express estrogen-binding sites, most likely presynaptically within the VPG itself, and (2) estrogen treatment will lead to rapid increases in local mu-opioid concentrations accompanied by rapid internalization of mu-opioid receptors in the VPG region of midshipman.
This study demonstrates that steroids and neuropeptides can interact in the minute-by-minute control of motor network patterning, suggesting that acute shifts in midshipman calling behavior in nature involve combined rapid actions of estrogens and opioids (Fig. 1) . Our Wndings are consistent with a mechanism of second-order, or "meta"-modulation, in which the actions of one neuromodulator (in this case E 2 ) inXuence the actions of an existing neuromodulatory circuit (in this case mu-opioid neurons). Metamodulation provides an important mechanism for generating a broad range of behavioral states from a discrete network of neurons (Katz and Edwards 1999; Mesce 2002; McLean and Sillar 2004) . Metamodulation is likely an important mechanism for shaping vocal output in midshipman, since the neuropeptides arginine vasotocin and isotocin also exert rapid actions on Wctive calling in this species (Goodson and Bass 2000) .
The current results suggest that the steroid-sensitive neural circuitry that patterns vocal production in other vertebrates (Schlinger and Brenowitz 2002; Bass and RemageHealey 2008; Jurgens 2008) , could be regulated by acute steroid/opioid interactions similar to those in this study. Thus far, evidence has been suggestive in favor of this hypothesis. Masculinization of "crow" vocalizations in quail involves a testosterone-dependent upregulation of opioid binding sites in the brainstem (Bernroider et al. 1996) . In addition, peripheral injections of opioid receptor antagonists increase male song production in starlings (Riters et al. 2005) . However, to our knowledge neurophysiological evidence that opioids and steroids interact to regulate vocal patterning does not exist for birds and mammals. The mammalian hypothalamus exhibits sexually dimorphic expression of opioid peptides, and some neurons co-express mRNA for steroid receptors and opioids (Gu and Simerly 1994; Roepke et al. 2007 ). Therefore, rapid interactions between opioid-and steroid-dependent mechanisms, such as those outlined in this study, could be especially important for sex diVerences in brain function and behavioral plasticity in vertebrates. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
